Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

Running, not enrolling · Not applicable

Conditions studied: Metabolic Dysfunction Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease (NAFLD)

In brief

This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.

Key facts

Study ID

NCT06218589

Run by

Emory University

People needed

200

Starts

2024-01-18

Expected to finish

2027-02-01

Last updated by the study team

2026-04-08

Who can join

Age: 2 and older, up to 20. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females age 2-20 years with suspicion of MASLD or presenting to liver clinic for evaluation of liver disease, including possible MASLD
• For participants choosing to do MRI they have to be able to undergo MRI without sedation
• Written/verbal informed consent from parent or legal guardian
• Written/verbal informed assent from the child when indicated by age

You may not qualify if…

• Ascites
• Pregnancy
• Failure to give consent or assent
• Have an implanted electronic device such as pacemaker, neurostimulator, or cochlear implant

Where it is running

• Children's Healthcare of Atlanta (CHOA) — Atlanta, Georgia, United States
• Emory Children's Center — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.